New York, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Leukapheresis Market: Key Insights
According to our new research study on “Leukapheresis Market to 2028 – Global Analysis and Forecast – by Product Type, Application, End User, and Geography,” the Leukapheresis Market is projected to reach 133.90 million in 2028 from US$ 74.48 million in 2021; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028. The high cost of leukapheresis is expected to obstruct the growth of the market to a certain extent during the forecast years.
Leukapheresis Market: Competition Landscape and Key Developments
Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation Terumo Corporation, STEMCELL Technologies Inc., HemaCare, Macopharma, AllCells, STEMEXPRESS, and BioIVT amongst others are among the leading companies operating in the leukapheresis market. Leading players focus on expanding as well as diversifying their market presence and acquiring a new customer base, thereby tapping prevailing business opportunities.
In June 2019, StemExpress announced the release of their Frozen Leukopak. Additionally, this new format can be customized per client request. For example, one Leukopak can be split, frozen and shipped to multiple laboratories involved in the same study or to compare laboratory staff competencies, equipment functionality, data analysis and reporting.
Get Exclusive Sample Pages of Leukapheresis Market - COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00005515/
In November 2018, HemaCare Corporation announced their involvement as a provider of leukapheresis process development material for 100% of the current FDA-approved immunocellular therapies. HemaCare worked collaboratively with each company to source healthy donors per project requirements.
In November 2018, BioIVT has acquired Biological Specialty Corporation (BSC), a supplier of human blood products and components to the life sciences research community for more than 37 years. BSC is headquartered in Colmar, PA, with two additional FDA-registered donor centers in Allentown, PA and Reading, PA.
In 2020, North America dominated the leukapheresis market, and the US was the largest shareholder in the regional market. Further, Asia Pacific is expected to register the highest CAGR in the market during 2021–2028. The market growth in North America is ascribed to the presence of major market players. Additionally, increasing incidence and prevalence of leukemia and growing demand for leukopaks for research applications will further drive the regional growth. There are an estimated 399,967 people living with or in remission from leukemia in the U.S. as per The Leukemia & Lymphoma Society. The high incidence of leukemia globally is said to drive the Leukapheresis market.
Additionally, increasing prevalence of chronic disease and government initiatives for the implementation of leukapheresis for plasma therapy during COVID019 is also estimated to generate favorable environment for the market growth in Canada and Mexico.
Download Sample PDF Brochure of Leukapheresis Market Growth Research Report at https://www.theinsightpartners.com/sample/TIPRE00005515/
Strategic Activities by Leukapheresis Market Players Boost Market Growth:
The leukapheresis market players focus on introducing innovative products through extensive strategic activities. These devices are likely to produce superior treatment outcomes, compared to existing products in the market. AllCells, announced the addition of Cryopreserved Leukopaks to their extensive product portfolio. With AllCells' new Cryopreserved Leukopaks, customers have access to high-quality primary cells whenever they need them without worrying about potential delivery delays that can be associated with fresh cells.
AllCells, announced that they had expanded their portfolio of primary cells with the launch of the Guaranteed Cell-count Leukopaks. Their Guaranteed Cell-count Leukopaks are filled to deliver no less than 10 Billion, 5 Billion or 2.5 Billion cells at release.
Fresenius Kabi inaugurated the major expansion of the company’s production site in the Dominican Republic. In Haina, just outside the Dominican Republic’s capital and biggest city, Santo Domingo, the company manufactures apheresis sets. These products are used, for example, to collect blood components such as platelets or plasma. Fresenius Kabi undertook the expansion to meet the rising demand for these high-quality disposables used for critically important donations.
Leukapheresis Market: Segmental Overview
The leukapheresis market has been segmented on the bases of product type, application, and end user. The leukapheresis market, by product type, is segmented into leukapheresis devices, leukapheresis disposables. In 2021, the leukapheresis disposables segment held the largest share of the market, by product type. Whereas, leukapheresis devices segment of leukapheresis market is expected to witness fastest CAGR during 2021 to 2028. Based on application, the leukapheresis market has been segmented into research applications and therapeutic applications. In 2021, the research applications segment held the largest share of the market, by application and the segment is expected to grow at the fastest CAGR of 9.0% during the coming years. Based on end user, the leukapheresis market has been segmented into pharmaceutical and biotechnology companies, academic and research institutes, blood component providers and blood centers and hospitals and transfusion centers. In 2021, the blood component providers and blood centers segment held the largest share of the market, by technology. Whereas the hospitals and transfusion centers segment is expected to grow at the fastest CAGR of 9.3% during the coming years.
Order a Copy of Leukapheresis Market Shares, Strategies and Forecasts 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPRE00005515/
Many countries are declaring more cases each day now than they were during the first wave earlier this year. Lockdowns are being reintroduced in UK, Spain and Italy, and Ireland, as per the European Centre for Disease Prevention and Control (ECDC). Due to the second wave of COVID-19 cases, the government of many countries is working towards scaling up testing capacity, which is driving the growth of the market.
In the optimistic scenario, it could be assumed that the pandemic has created a positive impact on the leukapheresis market. The ongoing clinical trials for COVID-19 vaccines could positively impact the leukapheresis products market, as the study of white blood cells is integral in supporting vaccine development. Moreover, some studies are also being carried out to understand the overall effect of COVID-19 on white blood cells. For instance, the NIH is conducting clinical trials that require leukapheresis to understand the effect of SARS-CoV-2 on lymphocytes. In the pessimistic scenario, it could be assumed that the COVID-19 pandemic has drastically lowered the demand for leukapheresis, especially for research purposes, and also reduced the demand for leukopaks. Therapeutic leukapheresis could be classified under essential procedures and, hence, would have resumed early post the stringent regulations, which were imposed in the first and second quarter of 2020 in many parts of the world. However, clinical trials were disrupted during this period and have not fully recovered in the post-lockdown period. This could affect the future demand for leukopaks in the pessimistic scenario.
Further, a team of physicians at the dialysis center Diamedikum in Potsdam, Germany, have for the first time successfully treated a Covid-19 patient with a specific blood separation procedure to decrease CRP levels. CRP apheresis was crucial in improving the critical condition of the 53-year-old patient and most likely to avoid intensive care
Browse Related Reports:
Blood Test Equipment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Haemoglobin Meter, Blood Cell Counter, Erythrocyte Sedimentation Rate Analyzer, Others); Application (Hospital, Clinic, Blood Bank, Ambulatory Surgical Center, Others) and Geography - https://www.theinsightpartners.com/reports/blood-test-equipment-market
Blood Component Utilization Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Plasma, Red Blood Cells, Platelets); Application (Body Contouring, Skin Rejuvenation and Resurfacing, Others) - https://www.theinsightpartners.com/reports/blood-component-utilization-market
Pathogen Reduction System Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Semi-Automated Pathogen Reduction System, Fully-Automated Pathogen Reduction System); Type (Plasma Pathogen Reduction, Whole blood Pathogen Reduction, Platelets Pathogen Reduction); Application (Viruses , Bacteria, Parasites, White Blood Cells); End User (Hospitals , Ambulatory Surgical Center , Research Centers, Blood Banks, Others), and Geography - https://www.theinsightpartners.com/reports/pathogen-reduction-system-market
Blood Glucose Monitoring Systems Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Self-Monitoring Blood Glucose Systems, Continuous Glucose Monitoring Systems); Testing Type (Invasive, Non-Invasive); Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) - https://www.theinsightpartners.com/reports/blood-glucose-monitoring-systems-market
Blood Flow Survey Meter Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Doppler Blood Flow Survey Meter, Electromagnetic Blood Flow Survey Meter); Application (Haemodialysis, Research, Intensive Care, Surgery, Others) - https://www.theinsightpartners.com/reports/blood-flow-survey-meter-market
Blood Coagulation Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Systems, Consumables, Reagents, Accessories); Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, Other Technologies); Test Type (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, Platelet Function Tests, Other Coagulation Tests) - https://www.theinsightpartners.com/reports/blood-coagulation-testing-market
Blood Bags Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Product (Single Collection, Double Collection, Triple Collection, Quadruple Collection, and Others), End User (Hospitals, Diagnostic Centers, Research Laboratories, and Others), and Geography - https://www.theinsightpartners.com/reports/blood-bags-market
Blood Circulation Machine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Acupressure Therapy, Vibration Therapy, Mental Therapy, Others); Application (Arthritis, Varicose veins, Nerve atrophy, Others) and Geography - https://www.theinsightpartners.com/reports/blood-circulation-machine-market
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release - https://www.theinsightpartners.com/pr/leukapheresis-market
Connect With Us on:
LinkedIn: https://www.linkedin.com/company/7591674/admin/
Twitter: https://twitter.com/tipmarkettrends
Facebook: https://www.facebook.com/theinsightpartners/
YouTube: https://www.youtube.com/c/TheInsightPartners
RSS/Feeds: https://www.theinsightpartners.com/feed/
